Showing results (921-930 of 1,020) with videos related to

Sort By:
Pageof 102
Cancer Research Communications|October 6, 2025
Development and Application of MiMouse, a Comprehensive Genomic Profiling Panel for Credentialing Mouse Tumor ModelsKevin Hu, Chia-Jen Liu, Zhaoping Qin, et al.
Cancer Research Communications|August 19, 2025
Novel pre-treatment autoantibodies correlate with enfortumab vedotin-related dermatologic events in patients with advanced urothelial cancerEvangelia Vlachou, Burles A Johnson Iii, David J McConkey, et al.
Cancer Research Communications|August 18, 2025
GALNT7 Stratifies dMMR/MSI Colorectal Cancer into Distinct Molecular Subsets Associated with Prognosis and PD-L1 ExpressionHiroya Suzuki, Hirokazu Okayama, Shotaro Nakajima, et al.
Cancer Research Communications|August 13, 2025
Utilizing Serum-Derived Lipidomics with Protein Biomarkers and Machine Learning for Early Detection of Ovarian Cancer in the Symptomatic PopulationBrendan M Giles, Rachel Culp-Hill, Robert A Law, et al.
Cancer Research Communications|August 8, 2025
Characterization of Mutational Signatures in Tumors from a Large Chinese PopulationAaron Chevalier, Tao Guo, Natasha Q Gurevich, et al.
Cancer Research Communications|August 12, 2025
A Phase I, Open-Label, Dose Escalation Study of Enoblituzumab in Children and Young Adults with B7-H3-Expressing Relapsed or Refractory Solid TumorsKenneth B DeSantes, Kimberly A McDowell, Paul M Sondel, et al.
Cancer Research Communications|February 16, 2026
BRAFV600E Expression in c-Kit+ Interstitial Cells of Cajal Drives Gastrointestinal Stromal Tumor Formation in MiceFrancesco Tomassoni-Ardori, Karlyne M Reilly, Colleen Barrick, et al.
Cancer Research Communications|February 12, 2026
Weight Loss Patterns and Clinical Outcomes of GLP1 Receptor Agonists in Breast Cancer SurvivorsJasmine S Sukumar, Akshara Singareeka Raghavendra, Sarah Pasyar, et al.
Cancer Research Communications|November 16, 2022
Na+/H+-exchanger 1 enhances antitumor activity of engineered NK-92 natural killer cellsYao-Yu Gong, Hongguang Shao, Yu Li, et al.
Cancer Research Communications|November 16, 2022
Bcl-xL inhibition radiosensitizes PIK3CA/PTEN wild-type triple negative breast cancers with low Mcl-1 expressionAndrea M Pesch, Benjamin C Chandler, Anna R Michmerhuizen, et al.
Pageof 102